According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients requiring lifelong hydroxocobalamin 1mg intramuscularly every 23 months following initial loading doses Patients with gastrointestinal disorders including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians though oral supplementation is usually sufficient unless malabsorption is present Elderly patients who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women with confirmed deficiency (hydroxocobalamin for malabsorption
Without adequate B12, youre also more likely to experience symptoms like chronic pain, depression, and fatigue, each of which makes it harder to get the physical activity you need to drop extra pounds and keep weight gain at bay
Research shows this specific molecular arrangement is responsible for its potent NNMT inhibitory effects
04 Longevity Research Peptides and compounds explored in longevity and cellular-aging research contexts
Anti-inflammatory peptides like KPV may help control the inflammatory cascade that drives facet arthritis progression
HCMV, human cytomegalovirus
